Affinity Technologies has appointed J. Michael Edwards as Chief Financial Officer. Takeaway Points bioAffinity Technologies ...
Affinity Technologies' CyPath® Lung test will be added to the Federal Supply Schedule to help veterans and active military at ...
More doctors are ordering bioAffinity Technologies' CyPath Lung test and sales are skyrocketing. A long-term military health ...
Affinity Technologies today announced it appointed J. Michael Edwards as chief financial officer in September.
If a doctor suspects possible cancer, a non-invasive at-home test helps determine the next step in days, rather than months.
CyPath Lung is a laboratory-developed assay that uses self-collected sputum samples treated with a fluorescent compound that preferentially binds to cancer cells and cancer-related cells, San ...
Pandabuy is a Chinese shopping agent that allows international users to access products from Chinese marketplaces like Taobao ...
Residents are worried about the effect on their drinking water while business leaders are optimistic about the new jobs.
BAZAAR interviews Marie-Hélène Lair of Clarins Group, about epigenetics in skincare, Clarins' new Double Serum and its ninth ...
The Canadian Press on MSN4d
S&P/TSX composite slides as oil gives up some of its recent gainsCanada’s energy-heavy main stock index sank further into the red on Tuesday, weighed down by retreating oil prices.
Edwards will report directly to bioAffinity Technologies President and CEO Maria Zannes. "We are delighted to welcome Michael ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback